V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 3.14 USD 0.64% Market Closed
Market Cap: 85m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

Net Margin
VistaGen Therapeutics Inc

-3 412.6%
Current
4 449%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-3 412.6%
=
Net Income
-33.2m
/
Revenue
972.7k

Net Margin Across Competitors

Country Company Market Cap Net
Margin
US
VistaGen Therapeutics Inc
NASDAQ:VTGN
85m USD
-3 413%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
352.5B USD
9%
US
Amgen Inc
NASDAQ:AMGN
174.8B USD
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.2B USD
-5%
US
Gilead Sciences Inc
NASDAQ:GILD
120.3B USD
0%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
AU
CSL Ltd
ASX:CSL
137.9B AUD
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
91.2B USD
34%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
33.2B EUR
-14%
Country US
Market Cap 85m USD
Net Margin
-3 413%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 352.5B USD
Net Margin
9%
Country US
Market Cap 174.8B USD
Net Margin
13%
Country US
Market Cap 133.2B USD
Net Margin
-5%
Country US
Market Cap 120.3B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 137.9B AUD
Net Margin
18%
Country US
Market Cap 91.2B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 33.2B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for VistaGen Therapeutics Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-3 412.6%
=
Net Income
-33.2m
/
Revenue
972.7k
What is the Net Margin of VistaGen Therapeutics Inc?

Based on VistaGen Therapeutics Inc's most recent financial statements, the company has Net Margin of -3 412.6%.